LEADER 00893nam0 2200289 450 001 000015354 005 20181030124538.0 100 $a20080819d1960----km-y0itay50------ba 101 0 $aeng 102 $aGB 105 $ay-------001yy 200 1 $a<>textbook of economic theory$fby Alfred W. Stonier and Douglas C. Hague 205 $a2nd ed. 210 $aLondon$cLongmans$d1960 215 $aX, 513 p.$d23 cm 610 1 $aEconomia 610 1 $aEconomia$aTeorie 676 $a330$v18$9Economia 676 $a330.1$v16$9Sistemi e teorie economiche 676 $a330.01$v20$9Economia. Filosofia e teoria 700 1$aStonier,$bAlfred W.$068496 701 1$aHague,$bDouglas Chalmers$0569004 801 0$aIT$bUNIPARTHENOPE$c20080819$gRICA$2UNIMARC 912 $a000015354 951 $a338.01/104$b15859$cNAVA4 996 $aTextbook of economic theory$91202773 997 $aUNIPARTHENOPE LEADER 03550nam 2200637Ia 450 001 9910144105303321 005 20170815110036.0 010 $a1-281-84083-1 010 $a9786611840839 010 $a0-470-71516-2 010 $a0-470-71485-9 035 $a(CKB)1000000000553096 035 $a(EBL)366840 035 $a(OCoLC)437234433 035 $a(SSID)ssj0001651547 035 $a(PQKBManifestationID)16425550 035 $a(PQKBTitleCode)TC0001651547 035 $a(PQKBWorkID)14977368 035 $a(PQKB)10820993 035 $a(SSID)ssj0000715085 035 $a(PQKBManifestationID)11394646 035 $a(PQKBTitleCode)TC0000715085 035 $a(PQKBWorkID)10700944 035 $a(PQKB)11435829 035 $a(MiAaPQ)EBC366840 035 $a(EXLCZ)991000000000553096 100 $a20070522d1951 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCIBA Foundation conference on isotopes in biochemistry$b[electronic resource] 210 $aLondon $cJ & A Churchill, Ltd.$d1951 215 $a1 online resource (315 p.) 225 1 $aNovartis Foundation Symposia ;$vv.806 300 $aIncludes index. 311 $a0-470-71468-9 327 $aIsotopes in Biochemistry; Foreword; Contents; Opening Address; Part I-Steroids; Metabolism of 14C-labelled steroids; High cholesterol content of human spleen; The biosynthesis of radioactive cholesterol br surviving liver slices; Studies with deuterium steroids; Part II-Hbmoglobin and Metabolic Derivatives; The biosynthetic mechanism of porphyrin formation; Studies on mammaIian red cells; Preliminary investigations for a study of energy utilized by the surviving fowl erythrocyte in hsem synthesis; Iron metabolism in pathological conditions 327 $aPart III-Use of Tracers in the Study of Biological Effects of RadiationThe modification of X-ray sensitivity by chemicals; Effect of X-rays on nucleic acid and protein synthesis in the Jensen rat sarcoma; Radiation dose in tracer experiments involving auto-radiography; Synthesis of deoxyribose nucleic acid and nuclear incor- poration of 35S shown by autoradiographs; Part IV-Nucleic Acids; The biosynthesis of pyrimidines in vitro; Studies with organic- and bio-synthetic nucleosides and nucleotides; The use of radiophosphorus in the study of the nucleic acids 327 $aRate of synthesis and quantitative variations of the ribo- nucleic acid during the growth of a culture of Polytomella coecaPart V-Proteins and Amino-Acids; A method for the evaluation of the rate of protein synthesis in man; Turnover rates during formation of proteins and poly- nucleotides in regenerating tissues; Synthesis of phenylalanine and tyrosine in yeast; Part VI-Carbohydrate and Fatty Acid Metabolism; A study of acetone metabolism, using glycogen and serine as indicators, and the role of C1-compounds in metabolism; Asymmetric citric acid 327 $aMode of formation of fatty acids from acetate and glucose, as studied in the mammary gland 410 0$aNovartis Foundation Symposia 606 $aRadioisotopes in biochemistry 606 $aBiochemistry$xResearch 608 $aElectronic books. 615 0$aRadioisotopes in biochemistry. 615 0$aBiochemistry$xResearch. 676 $a574.19 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910144105303321 996 $aCIBA Foundation conference on isotopes in biochemistry$91913934 997 $aUNINA LEADER 04489nam 22006855 450 001 9910254264903321 005 20250610110611.0 010 $a3-319-24535-X 024 7 $a10.1007/978-3-319-24535-5 035 $a(CKB)3710000000636316 035 $a(EBL)4504075 035 $a(SSID)ssj0001665931 035 $a(PQKBManifestationID)16455307 035 $a(PQKBTitleCode)TC0001665931 035 $a(PQKBWorkID)15000056 035 $a(PQKB)10570189 035 $a(DE-He213)978-3-319-24535-5 035 $a(MiAaPQ)EBC4504075 035 $a(PPN)193445573 035 $a(MiAaPQ)EBC29090765 035 $a(EXLCZ)993710000000636316 100 $a20160409d2016 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aConnective Tissue Disease $eA Comprehensive Guide - Volume 1 /$fedited by Dario Roccatello, Lorenzo Emmi 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (399 p.) 225 1 $aRare Diseases of the Immune System,$x2282-6505 300 $aDescription based upon print version of record. 311 08$a3-319-24533-3 320 $aIncludes bibliographical references and index. 327 $aPart 1 Systemic Lupus Erythematosus -- Introduction - SLE in 21st Century -- Epidemiologic aspects of SLE -- Immunopathogenesis of SLE -- Clinical aspects in SLE -- Autoantibodies and biomarkers: diagnostic aspects -- Joint involvement in Systemic Lupus Erythematosus -- Cutaneous manifestations of SLE -- Kidney Involvement in SLE -- NPSLE -- Cardiovascular issues in SLE -- SLE and Pregnancy -- Vitamin D endocrine system and SLE -- The impact of aPL detection on pregnancy -- SLE and APS -- Disease activity indices and prognosis of SLE -- Conventional therapy for SLE -- Biological Therapy in SLE -- Part 2 Sjögren Syndrome -- Classification criteria for Sjögren syndrome -- Pathogenesis of Sjögren syndrome -- Autoantibodies in Sjögren syndrome and laboratory markers -- Parotid and Submandibular involvement in Sjögren syndrome -- Extraglandular involvement in Sjögren syndrome -- Dry eye in Sjögren syndrome: diagnostic tools and therapy -- Neurologic involvement in Sjögren syndrome -- Lymphoproliferative disorder in Sjögren syndrome -- Pathogenetic aspects of Sjogren Syndrome: Relationships with Cryoglobulinemia and Lymphoproliferation -- Systemic treatment of Sjögren syndrome. 330 $aIn this volume devoted to systemic lupus erythematosus (SLE) and Sjögren syndrome, leading specialists from different disciplines present the latest research findings on many aspects of the diseases and describe the most recent trends in treatment, such as the ?treat to target? approach. Both basic science and clinical medicine are addressed, with emphasis on the most promising clinical and laboratory-based studies. The coverage is comprehensive in scope, encompassing, for example, epidemiology, pathogenesis, autoantibodies and biomarkers, disease manifestations, involvement of different organs or systems, relationships with other disorders, biological therapy of SLE, and systemic treatment of Sjögren syndrome. Readers will find this first volume of Connective Tissue Disease to be an excellent source of information on the current understanding of, and clinical approach to, SLE and Sjögren syndrome that clearly conveys the progress made in recent years. 410 0$aRare Diseases of the Immune System,$x2282-6505 606 $aRheumatology 606 $aImmunoglobulins 606 $aNephrology 606 $aRheumatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33170 606 $aAntibodies$3https://scigraph.springernature.com/ontologies/product-market-codes/B14010 606 $aNephrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33126 615 0$aRheumatology. 615 0$aImmunoglobulins. 615 0$aNephrology. 615 14$aRheumatology. 615 24$aAntibodies. 615 24$aNephrology. 676 $a616.77 702 $aRoccatello$b Dario$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aEmmi$b Lorenzo$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910254264903321 996 $aConnective Tissue Disease$92513367 997 $aUNINA